Vous consultez actuellement toutes les actualités boursières de l'instrument financier BRIACELL THERAPEUTICS sur tous les marchés dans toutes les langues.
EQS-News: BriaCell Therapeutics Corp. BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients 14.12.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing breast cancer mortality rate. As it...
EQS-News: BriaCell Therapeutics Corp. BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients 02.12.2022 / 16:00 CET/CEST The issuer is solely responsible for the content of this announcement. The world of biotech is having what some are calling a golden age . Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs like SPDR S&P Biotech (NYSEARCA: XBI) (“XBI”) and iShares...